Revolutionizing treatment for patients in need

View Our Pipeline
Scroll To Discover
Young woman smiling. Young woman smiling. Young woman smiling.

About

We’re committed to delivering boundless therapeutic ingenuity

Tarsus Pharmaceuticals, Inc. is a biopharmaceutical company that embodies the values of commitment, empowerment, and teamwork. We aim to bring novel therapeutics to patients across a range of diseases with limited treatment options.

Discover Tarsus

Product

Novel therapies, beginning with the eye

For the millions of patients living with Demodex blepharitis, an FDA-approved treatment is here.

Learn more

News & Media

Here is the latest from Tarsus

09/06/2023 Tarsus to Ring Nasdaq Stock Market Closing Bell in Celebration of the Launch of XDEMVY™, the First and Only FDA Approved Treatment for Demodex Blepharitis
08/30/2023 Tarsus to Present at Upcoming Investor Conferences
08/24/2023 Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis
XDEMVY logo

NOW AVAILABLE

GO TO XDEMVY.COM
If you are an eye care professional looking for product information, visit XDEMVYHCP.com.

Contact Tarsus

Please reach out to us using the form below.

"*" indicates required fields

Opt-in
This field is for validation purposes and should be left unchanged.